Company Stealth BioTherapeutics Corp
Equities
MITO
US85789A1051
Biotechnology & Medical Research
Business Summary
Number of employees: 38
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 01/15/01 | |
Martin Redmon
CTO | Chief Tech/Sci/R&D Officer | 62 | - |
James R. Carr
CTO | Chief Tech/Sci/R&D Officer | 61 | 17/14/17 |
Janhavi Mohite
IRC | Investor Relations Contact | - | - |
Anthony Walsh
PRN | Corporate Officer/Principal | - | 01/22/01 |
Mike Malynn
HRO | Human Resources Officer | - | - |
Brian Hotchkiss
PRN | Corporate Officer/Principal | - | - |
Brian Blakey
PRN | Corporate Officer/Principal | 61 | 01/14/01 |
Henry H. Hess
LAW | General Counsel | 51 | 01/11/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 78 | 04/20/04 | |
Louis Lange
BRD | Director/Board Member | 72 | 24/19/24 |
Kevin McLaughlin
BRD | Director/Board Member | 67 | 14/17/14 |
Edward Owens
BRD | Director/Board Member | 77 | 24/17/24 |
Francis Chen
BRD | Director/Board Member | 75 | 20/06/20 |
Lok Chung Chan
CHM | Chairman | 73 | 22/07/22 |
Chief Executive Officer | 59 | 01/15/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 717,261,322 | 28,068,000 ( 3.913 %) | 0 | 3.913 % |
Company contact information
Stealth BioTherapeutics Corp.
140 Kendrick Street Buidling C-West
024494, Needham
+
http://www.stealthbt.comSector
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |